IOL Chemicals & Pharmaceuticals Ltd Annually Results

Gross Sales

2,079.21

2,132.79

2,217.11

2,184.02

Excise Duty

0

0

0

0

Net Sales

2,079.21

2,132.79

2,217.11

2,184.02

Other Operating Income

0

0

0

0

Other Income

22.41

30.07

25.61

32.04

Total Income

2,101.62

2,162.86

2,242.72

2,216.06

Total Expenditure

1,876.91

1,902.2

1,991.44

1,939.66

PBIDT

224.71

260.66

251.28

276.4

Interest

14.76

16.1

16.47

8.29

PBDT

209.95

244.56

234.81

268.11

Depreciation

71.99

62.91

46.16

43.26

Minority Interest Before NP

0

0

0

0

Tax

24.74

37.01

46.26

57.01

Deferred Tax

12.15

10.21

3.25

0.17

Reported Profit After Tax

101.07

134.43

139.14

167.67

Minority Interest After NP

0

0

0

0

Net Profit after Minority Interest

101.07

134.43

139.14

167.67

Extra-ordinary Items

0

0

0

-10.39

Adjusted Profit After Extra-ordinary item

101.07

134.43

139.14

178.06

EPS (Unit Curr.)

3.44

22.9

23.7

28.56

Book Value (Unit Curr.)

0

0

0

0

Dividend (%)

200

50

40

40

Equity

58.71

58.71

58.71

58.71

Public Shareholding (Number)

0

0

0

0

Public Shareholding (%)

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

PBIDTM(%)

10.8

12.22

11.33

12.65

PBDTM(%)

10.09

11.46

10.59

12.27

PATM(%)

4.86

6.3

6.27

7.67